维普中文期刊产品整合服务
20篇 您的检索式:作者名="Castle TC"
    题名 作者 年代 出处 被引量
1Investigation into ^64Cu-labeled Bis (selenosemicarbazone)and Bis (thiosemicarbazone) complexes as hypoxia imaging agents 显示文摘McQuade P Martin KE Castle TC 2005Nucl Med Biol2005,32,2:1
2Performance of carcino- genic human papillomavirus (HPV) testing and HPV16 or HPVI8 genotyping for cervical cancer screening of women aged 25 years and older:a subanalysis of the ATHENA study 显示文摘Castle PE Stoler MH Wright TC Jr 2011Lancet Oncol2011,12,9:1
3Performance of carcinogenic humanpapillomavirus(I-IPV) testing and HPV16 or HPV18 genoty- ping for cervical cancer screening of women aged 25 years and older: a subanalysis of the ATHENA study显示文摘Castle PE Stoler MH Wright TC 2011Lancet Oncol2011,12,9:1
4Performance of carci-nogenic human papillomavirus (HPV) testing and HPV1 6 or HPV18 genotyping for cervical cancer screening of women aged 25 years and older:a subanalysis of the ATHENA study显示文摘Castle PE Stoler MH Wright TC Jr 0,,9:1
5Performance of carcinogenic human papillomavirus(HPV)testing and HPV16 or HPV18 genotyping for cervical cancer screening of women aged 25 years and older: a subanalysis of the ATHENA study 显示文摘Castle PE Stoler MH Wright TC Jr 2011Lancet Oncol2011,12,9:1
6Performance of carci nogenic human papillomavirus (HPV) testing and HPV16 or HPV18 genotyping for cervical cancer screening of women aged 25 years and older=a subanalysis of the ATHENA study显示文摘Castle PE Stoler MH Wright TC Jr 2011Lancet Oncol2011,12,9:1
7Performance of carcino- genic human papillomavirus (HPV) testing and HPV16 or HPV18 geuotyping for cervical cancer screening of women aged 25 years and older : a subanalysis of the ATHENA study显示文摘Castle PE Stoler MH Wright TC Jr 2011Lancet Oncol2011,12,9:1
8Pertbrmance of carcinogenic human papillomavirus (HPV) testing and HPV16 or HPV 18 geno- typing for cervical cancer screening of women aged 25 years anti ohter: a sul)analysis of the ATHENA study 显示文摘Castle PE Stoler M H Wright TC Jr 2011Lancet Oncol2011,12,9:1
9Performance of carcino- genic humanpapillomavirus (HPV) testing and HPV16 or HPV18 genotyping for cervical cancer screening of women aged 25 years and older: a subanalysis of the ATHENA study显示文摘Castle PE Stoler MH Wright TC 2011Lancet Oneol2011,12,9:1
10Performance of carcinogenic human papiUomavirus (HPV) testing and HPV16 or HPV18 genotyping for cervical cancer screening of women aged 25 years and older: a subanalysis of the ATHENA study 显示文摘Castle PE Stoler MH Wright TC 2011Lancet Oncol2011,12,9:1
11Performance of carcinogenic hu- man papillomavirus (HPV) testing and HPV16 or HPV18 genotyping for cervical cancer screening of women aged 25 years and older: a subanalysis of the ATHENA study显示文摘Castle PE Stoler MH Wright TC Jr 2011Lancet Oncol2011,12,9:1
12Performance of carcinogenic human papillomavirus (HPV) testing and HPV16 or HPV18 genotyping for cervical cancer screening of women aged 25 years and older:a subanalysis of the ATHENA study显示文摘Castle PE Stoler MH Wright TC Jr 0,,09:1
13Investigation into 64Cu-labeled Bis(selenosemicarbazone) and Bis(thiosemicarbazone) complexes as hypoxia imaging agents显示文摘McQuade P Martin KE Castle TC 2005Nucl Med Biol2005,32,2:1
14Cervical cancer screening in low-resource settings: A cost-effectiveness framework for valuing tradeoffs between test performance and program coverage 显示文摘Campos NG Castle PE Wright TC Jr 2015Int J Cancer2015,137,9:1
15Performance of carcinogenic human papillomavirus (HPV) testing and HPV16 or HPV18 genotyping for cervical cancer screening of women aged 25 years and older a subanalysis of the ATHENA study显示文摘Castle PE Stoler MH Wright TC Jr 2011Lancet Oncol2011,12,9:1
16Performance of carcinogenic human papillomavirus (HPV) testing and HPV16 or HPV18 genotyping for cervical cancer screening of women aged 25 years and older: a subanalysis of the ATHE- NA study 显示文摘Castle PE Stoler MH Wright TC Jr 2011Lancet Oncol2011,12,9:1
17Cervical cancer screening in low-resource settings: A cost-effectiveness framework for valuing tradeoffs between test performance and program coverage显示文摘Campos NG Castle PE Wright TC Jr 2015Int J Cancer2015,137,9:1
18Performance of carcinogenic human papillomavirus(HPV)testing and HPV16 or HPV18 genotyping for cervical cancer screening of women aged 25 years and older:a subanalysis of the ATHENA study显示文摘Castle PE Stoler MH Wright TC 2011Lancet Oncol2011,12,9:1
19Performance of carcinogenic human papillomavirus (HPV) testing and HPV16 or HPV18 genotyping for cervical cancer screening of women aged 25 years and older: a subanalysis of the ATHE- NA study显示文摘Castle PE Stoler MH Wright TC 2011Lancet Oncol2011,12,9:1
20Performance of carcinogenic human papillomavirus (HPV) testing and HPV16 or HPV18 genotyping for cervical cancer screening of women aged 25 years and older: a subanalysis of the ATHENA study显示文摘Castle PE Stoler MH Wright TC Jr 2011Lancet Oneol2011,12,:1
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费